Versant Capital Management, Inc

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1735057 PHOENIX, AZ

Position in HALO

as of Sep 30, 2026 · filed Oct 2, 2026 Compact

Position Value

$188,121

+$55,610 QoQ

Shares Held

1,704

+0.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 15 holders

Holding Since

Jun 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Sep 30, 2026

Versant Capital Management, Inc holds $6,648,536 across 141 Biotechnology names. HALO ranks #7 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	2,886	$668,166
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,098	$574,045
3	MRNA	Moderna, Inc.	2,491	$479,691
4	GMAB	Genmab A/S	12,235	$436,483
5	REGN	Regeneron Pharmaceuticals, Inc.	534	$404,916
6	ARGX	Argenx SE	414	$396,988
7	HALO	Halozyme Therapeutics, Inc. This page	1,704	$188,121
8	ALNY	Alnylam Pharmaceuticals, Inc.	652	$160,874

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-09-30	$188,121	1,704	+0.6%	Shares	Sole	2026-10-02
2026-06-30	$132,511	1,693	+37.3%	Shares	Sole	2026-07-02
2026-03-31	$79,688	1,233	0.0%	Shares	Sole	2026-04-07
2025-12-31	$82,980	1,233	0.0%	Shares	Sole	2026-01-08
2025-09-30	$90,428	1,233	+4.8%	Shares	Sole	2025-10-27
2025-06-30	$61,175	1,176	+168.5%	Shares	Sole	2025-07-07
2025-03-31	$27,948	438	0.0%	Shares	Sole	2025-04-03
2024-12-31	$20,940	438	+1985.7%	Shares	Sole	2025-01-03
2024-09-30	$1,202	21	0.0%	Shares	Sole	2024-10-07
2024-06-30	$1,099	21	0.0%	Shares	Sole	2024-07-08
2024-03-31	$854	21	0.0%	Shares	Sole	2024-04-03
2023-12-31	$776	21	0.0%	Shares	Sole	2024-01-08
2023-09-30	$802	21	0.0%	Shares	Sole	2023-10-12
2023-06-30	$757	21	—	Shares	Sole	2023-07-10
No filing history on record for this holder in this stock.